Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Cutaneous trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Cutaneous Phase: Phase 2 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20101
20114
20162
20172
20212
20223
20232
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Gilead Sciences2
University Hospital Muenster2
Beijing InnoCare Pharma Tech Co., Ltd.1
Biogen1
Bristol-Myers Squibb1
EMD Serono Research & Development Institute, Inc.1
Emory University1
Heinrich-Heine University, Duesseldorf1
Immunovant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Cutaneous22
Lupus Erythematosus, Discoid8
Lupus Erythematosus, Systemic5
Connective Tissue Diseases1
Immune System Diseases1
Skin Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.